Myofascial pain syndrome after head and neck cancer treatment: Prevalence, risk factors, and influence on quality of life

Cardoso, Letícia Rodrigues; Rizzo, C.; Oliveira, Cleyton Zanardo de; Santos, Carlos Roberto dos; Carvalho, André Lopes

doi:10.1002/hed.23825

Cited by 27 publications

(11 citation statements)

References 16 publications

(16 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In prior studies that evaluated neck disability through clinical assessment and evaluation, the prevalence ranged from 11% to 77%. 24,32,33 Marital status and treatment type were significantly associated with neck disability. Married patients were less likely to report neck disability ( P = .004).…”

Section: Discussionmentioning

confidence: 93%

“…In a previous study of 167 patients, myofascial pain syndrome, which is characterized by intense, deep pain and limited range of motion, was associated with lower overall QOL. 33 Studies have linked neck dissection with lower QOL, 36,37 but most of these studies focus on impairment of the shoulder. 37 Further work needs to be done to explore the phenomenon of neck impairment, including impairments in range of motion, posture, and presence of pain in nonsurgical patients and the relationship with QOL.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Impact of Neck Disability on Health‐Related Quality of Life among Head and Neck Cancer Survivors

Nilsen

Lyu

Belsky

et al. 2019

Otolaryngol.--head neck surg.

View full text Add to dashboard Cite

Objective Although neck impairment has been described following surgical resection, limited studies have investigated its prevalence in nonsurgical treatment. The purpose of this study is to determine the prevalence and predictors of neck disability following head and neck cancer (HNC) treatment and to explore its association with quality of life (QOL). Study Design Cross-sectional study. Setting HNC survivorship clinic. Subjects and Methods We identified 214 survivors who completed treatment ≥1 year prior to evaluation in the clinic. Self-reported neck impairment was measured using the Neck Disability Index. QOL was measured using the University of Washington QOL Questionnaire, with physical and social subscale scores calculated. Regression analysis and trend tests were employed to explore associations. Results Over half of survivors (54.2%) reported neck disability. The odds of neck disability in survivors who received nonsurgical treatment and those who received surgery plus adjuvant treatment were 3.46 and 4.98 times higher compared to surgery alone ( P = .008, P = .004). Survivors who underwent surgery only had higher physical and social QOL than those who received nonsurgical treatment (physical QOL: P < .001, social QOL: P = .023) and those who received surgery plus adjuvant treatment (physical QOL: P < .001, social QOL: P = .039). Conclusion This study revealed a high prevalence of neck disability following nonsurgical treatment. While neck disability is an established sequela of surgical resection, the impact of nonsurgical treatment has gone unrecognized. Early identification and intervention to prevent progression of neck disability are crucial to optimize QOL.

show abstract

Section: Discussionmentioning

confidence: 93%

Section: Discussionmentioning

confidence: 99%

Impact of Neck Disability on Health‐Related Quality of Life among Head and Neck Cancer Survivors

Nilsen

Lyu

Belsky

et al. 2019

Otolaryngol.--head neck surg.

View full text Add to dashboard Cite

show abstract

“…Similar results were reported by Cardoso et al in a prospective study, including 167 patients with head and neck cancer after a disease-free interval of a year or more. A total of 57% of patients reported significant pain, of which 11.9% was MPS, most often involving the upper trapezius muscle [ 33 ]. Recently, Ortiz-Comino et al compared the prevalence of trigger points in a case control study of 30 individuals with head and neck cancer suffering from cervical and/or temporomandibular pain with that of 30 matched pain-free controls.…”

Section: Methodsmentioning

confidence: 99%

The Case for Comorbid Myofascial Pain—A Qualitative Review

Vulfsons

Minerbi

2020

IJERPH

View full text Add to dashboard Cite

Myofascial pain syndrome is widely considered to be among the most prevalent pain conditions, both in the community and in specialized pain clinics. While myofascial pain often arises in otherwise healthy individuals, evidence is mounting that its prevalence may be even higher in individuals with various comorbidities. Comorbid myofascial pain has been observed in a wide variety of medical conditions, including malignant tumors, osteoarthritis, neurological conditions, and mental health conditions. Here, we review the evidence of comorbid myofascial pain and discuss the diagnostic and therapeutic implications of its recognition.

show abstract

“…MPS can be diagnosed by using pressure algometry for pain threshold evaluation [9]. Physical examination yields a palpable intramuscular band tension, muscle tenderness, and trigger points causing localized or referred pain [10]. Myofascial pain can be managed pharmacologically using non-steroidal anti-inflammatory drugs, antidepressants, anticonvulsants, and muscle relaxants; and non-pharmacologically using dry needling, trigger point injection (TPI), transcutaneous electrical nerve stimulation (TENS), and ultrasound (US) [11].…”

Section: Introductionmentioning

confidence: 99%

Efficacy of Extracorporeal Shockwave Therapy on Cervical Myofascial Pain Following Neck Dissection Surgery: A Randomized Controlled Trial

et al. 2020

View full text Add to dashboard Cite

Objective To investigate the efficacy of extracorporeal shockwave therapy (ESWT) on cervical myofascial pain following neck dissection in reducing pain and improving cervical range of motion (ROM).Methods Forty-six patients with cervical myofascial pain following neck dissection surgery were recruited and subdivided at random into two equal groups. The ESWT group received ESWT once a week for 4 weeks (0.25 mL/mm<sup>2</sup>, 1,000 shocks) and a topical non-steroidal anti-inflammatory drug (3 times/day for 4 weeks). The control group received only topical NSAID. The pain assessment was done by using the visual analog scale (VAS) and pressure algometry. A cervical ROM device was used for the assessment of the lateral flexion and rotation of the neck ROM on both sides. All measurements were collected at baseline, 2 weeks, and 4 weeks.Results The ESWT group revealed a significant improvement in all parameters at post I and post II than did the control group (p>0.001), that revealed a statistical decrease only in the VAS score at post I without any statistical difference in the pain threshold and neck ROM. However, there were statistical differences in all parameters at post II compared to those at pre-treatment and post I (p<0.001).Conclusion As a confirmation of the efficacy of ESWT in cervical myofascial pain control following neck dissection, we observed better results with no side effects in the ESWT group (Clinical Trial Registry No. PACTR202002648274347).

show abstract

Myofascial pain syndrome after head and neck cancer treatment: Prevalence, risk factors, and influence on quality of life

Abstract: Myofascial pain syndrome was observed in 1 of 9 patients after head and neck cancer treatment and a worse QOL was observed among them. Tumor site and neck dissection were found to be risk factors for myofascial pain syndrome.

Cited by 27 publications

References 16 publications

Impact of Neck Disability on Health‐Related Quality of Life among Head and Neck Cancer Survivors

Impact of Neck Disability on Health‐Related Quality of Life among Head and Neck Cancer Survivors

The Case for Comorbid Myofascial Pain—A Qualitative Review

Efficacy of Extracorporeal Shockwave Therapy on Cervical Myofascial Pain Following Neck Dissection Surgery: A Randomized Controlled Trial

Contact Info

Product

Resources

About